These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18692880)

  • 1. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
    Capitanio U; Ahyai S; Graefen M; Jeldres C; Shariat SF; Erbersdobler A; Schlomm T; Haese A; Steuber T; Heinzer H; Perrotte P; Péloquin F; Pharand D; Arjane P; Huland H; Karakiewicz PI
    Urology; 2008 Dec; 72(6):1208-11; discussion 1212-3. PubMed ID: 18692880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative prediction of pathologically insignificant prostate cancer in radical prostatectomy specimens: the role of prostate volume and the number of positive cores.
    Raventós CX; Orsola A; de Torres I; Cecchini L; Trilla E; Planas J; Morote J
    Urol Int; 2010; 84(2):153-8. PubMed ID: 20215818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
    Jeldres C; Suardi N; Walz J; Hutterer GC; Ahyai S; Lattouf JB; Haese A; Graefen M; Erbersdobler A; Heinzer H; Huland H; Karakiewicz PI
    Eur Urol; 2008 Dec; 54(6):1306-13. PubMed ID: 18083294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer.
    Hong SK; Han BK; Chung JS; Park DS; Jeong SJ; Byun SS; Choe G; Lee SE
    BJU Int; 2008 Nov; 102(9):1092-6. PubMed ID: 18671786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting.
    Villa L; Salonia A; Capitanio U; Scattoni V; Abdollah F; Suardi N; Dell'Oglio P; Freschi M; Montorsi F; Briganti A
    Urology; 2014 Sep; 84(3):634-41. PubMed ID: 25059594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Tsukamoto T; Ohkubo Y; Komai Y; Ishikawa Y; Fukui I
    Urology; 2008 Dec; 72(6):1224-8. PubMed ID: 18723208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".
    van Oort IM; Kok DE; Kiemeney LA; Hulsbergen-van de Kaa CA; Witjes JA
    Urol Oncol; 2009; 27(5):509-13. PubMed ID: 18625570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
    Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men.
    Lee SE; Kim DS; Lee WK; Park HZ; Lee CJ; Doo SH; Jeong SJ; Yoon CY; Byun SS; Choe G; Hwang SI; Lee HJ; Hong SK
    BJU Int; 2010 Jun; 105(11):1526-30. PubMed ID: 19912202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P; Fraggetta F; Galia A; Grasso G; Piccolo S; Aragona F
    Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy.
    DeCastro GJ; McCann T; Benson MC; McKiernan JM
    Urology; 2008 Dec; 72(6):1214-8. PubMed ID: 18597825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
    Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
    J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
    Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
    BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence.
    Bong GW; Ritenour CW; Osunkoya AO; Smith MT; Keane TE
    BJU Int; 2009 Feb; 103(3):327-31. PubMed ID: 19007381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.
    Rabbani F; Vora KC; Yunis LH; Eastham JA; Guillonneau B; Scardino PT; Touijer K
    BJU Int; 2009 Sep; 104(5):605-10. PubMed ID: 19689577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder neck preservation during radical retropubic prostatectomy and postoperative urinary continence.
    Razi A; Yahyazadeh SR; Sedighi Gilani MA; Kazemeyni SM
    Urol J; 2009; 6(1):23-6; discussion 26. PubMed ID: 19241337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival.
    Nguyen CT; Reuther AM; Stephenson AJ; Klein EA; Jones JS
    J Urol; 2009 Jan; 181(1):75-80. PubMed ID: 19012927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.